The journal of nutrition, health & aging · 2026
A Systematic Review and Meta-analysis on the association between sarcopenia and cognitive impairment in middle-aged and older adults from Latin America.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garrido-Dzib Angel Gabriel, Hernández-Chávez Saliha Karina, Rubio-Zapata Héctor, Jorquera Gonzalo, Gutiérrez-Solis Ana Ligia
Аннотация
OBJECTIVES: Reduction in skeletal muscle mass, strength, and function, such as sarcopenia, have been associated with cognitive impairment. In Latin America (LATAM), evidence remains scarce, a critical gap given the region's rapid demographic aging. Therefore, the present study aims to evaluate the association between sarcopenia and cognitive impairment among middle-aged and older adults in LATAM countries.
DESIGN: A systematic review and meta-analysis.
SETTING: A systematic literature search was conducted using PubMed, Web of Science, EMBASE, LILACS, SciELO and sources of grey literature. The association between sarcopenia and cognitive impairment (odds ratio) was pooled in a meta-analysis using a random-effects model. The quality of the methodology used in each study was evaluated using the JBI Critical Appraisal Tools.
PARTICIPANTS: Middle-aged and older adults from cross-sectional and longitudinal studies conducted in Latin American populations.
MEASURES: The primary outcome was the pooled association between sarcopenia and cognitive impairment.
RESULTS: A total of 8 studies and 13,395 community-dwelling adults were included. The meta-analysis showed that sarcopenia was associated with higher odds of cognitive impairment (OR = 2.30; 95% CI: 1.68-3.15). However, the magnitude of this association varied according to definition as probable cognitive impairment (OR = 2.56, 95% CI: 1.85-3.53, P < 0.001) and diagnosis criteria of sarcopenia by EWGSOP2 (OR = 2.96; 95% CI: 2.15-4.08, P < 0.001).
CONCLUSION: In LATAM, sarcopenia doubles the odds of cognitive impairment in adults. Future research must elucidate the inflammatory, oxidative, and mitochondrial pathways linking muscle and brain health.
DESIGN: A systematic review and meta-analysis.
SETTING: A systematic literature search was conducted using PubMed, Web of Science, EMBASE, LILACS, SciELO and sources of grey literature. The association between sarcopenia and cognitive impairment (odds ratio) was pooled in a meta-analysis using a random-effects model. The quality of the methodology used in each study was evaluated using the JBI Critical Appraisal Tools.
PARTICIPANTS: Middle-aged and older adults from cross-sectional and longitudinal studies conducted in Latin American populations.
MEASURES: The primary outcome was the pooled association between sarcopenia and cognitive impairment.
RESULTS: A total of 8 studies and 13,395 community-dwelling adults were included. The meta-analysis showed that sarcopenia was associated with higher odds of cognitive impairment (OR = 2.30; 95% CI: 1.68-3.15). However, the magnitude of this association varied according to definition as probable cognitive impairment (OR = 2.56, 95% CI: 1.85-3.53, P < 0.001) and diagnosis criteria of sarcopenia by EWGSOP2 (OR = 2.96; 95% CI: 2.15-4.08, P < 0.001).
CONCLUSION: In LATAM, sarcopenia doubles the odds of cognitive impairment in adults. Future research must elucidate the inflammatory, oxidative, and mitochondrial pathways linking muscle and brain health.